Yesterday I wrote an article for the purpose of illustrating how fundamental research can, in a relatively short time frame (~10 years), go from fundamental research to proven, industrial scale applied technology. These technological developments have the potential for great social benefit; assuming the developers are interested in those ends of course.



Yesterday, in Nature News, it was reported that a Rockville, Maryland based company named Sanaria has developed a malaria vaccine that, in their limited trials, has conferred 100% protection against malaria infection. That’s pretty remarkable considering the World Health Organization (WHO) had hoped for an 80% effective vaccine by 2025.

References:

– Seder, R. A. et al. 2013, Science